303 results on '"Valim, Valéria"'
Search Results
2. Prevalence of Sjögren's syndrome according to 2016 ACR-EULAR classification criteria in patients with systemic lupus erythematosus
3. Half dose ChAdOx1 nCoV-19 vaccine was equivalent to full doses to reduce moderate and severe COVID-19 cases
4. Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients
5. Brazilian version of the “Primary Sjögren’s Syndrome - Quality of Life questionnaire (PSS-QoL)”: translation, cross-cultural adaptation and validation
6. Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study.
7. Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2
8. Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination
9. EVENTOS ADVERSOS À 3ª DOSE DAS VACINAS ASTRAZENECA E PFIZER EM UMA COORTE DE TRABALHADORES DA SAÚDE
10. Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren’s syndrome: a randomized-controlled trial
11. Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose
12. Incidence of tuberculosis among patients with rheumatoid arthritis using TNF blockers in Brazil: data from the Brazilian Registry of Biological Therapies in Rheumatic Diseases (Registro Brasileiro de Monitoração de Terapias Biológicas – BiobadaBrasil)
13. Correction to: V Brazilian consensus guidelines for detection of anti-cell autoantibodies on hep-2 cells
14. The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritis.
15. Panoramic snapshot of serum soluble mediator interplay in pregnant women with convalescent COVID-19: an exploratory study
16. Quality of life in spondyloarthritis: analysis of a large Brazilian cohort
17. V Brazilian consensus guidelines for detection of anti-cell autoantibodies on hep-2 cells
18. Clinical risk factors for predicting anti-Sars-CoV-2 antibody immunoreactivity duration after mild COVID-19 infection
19. CARDIOVASCULAR RISK IN SJÖGREN S DISEASE FROM THE BRAZILIAN SJÖGREN S DISEASE REGISTRY (REBRAS)
20. HEALTH LITERACY IN PATIENTS WITH CHRONIC MUSCULOSKELETAL PAIN UNDER THE NATIONAL HEALTH SYSTEM (SUS)
21. SIALOADENITE LINFOCÍTICA FOCAL EM PACIENTE HIV: INFECÇÃO PELO HIV OU DOENÇA DE SJÖGREN? CASE REPORT
22. POSITIVITY OF ANTI-LA/SSB ANTIBODIES IN SJÖGREN S DISEASE IS ASSOCIATED WITH EXTRA-GLANDULAR SYSTEMIC MANIFESTATION: RESULTS FROM THE THE BRAZILIAN SJÖGREN S DISEASE REGISTRY (REBRAS)
23. THE EFFECT OF ANTIMALARIALS ON THE RISK AND SEVERITY OF BACTERIAL, VIRAL, FUNGAL AND SYSTEMIC SPECIFIC INFECTIONS IN RHEUMATOID ARTHRITIS
24. MAJOR SALIVARY GLANDS ULTRASOUND PREDICTS MORE SYSTEMIC MANIFESTATION IN PATIENTS WITH SJÖGREN S DISEASE
25. EFFECTS OF MANUAL VAGUS NERVE THERAPY COMBINED WITH TRANSCRANIAL DIRECT CURRENT STIMULATION ON PAIN IN WOMEN WITH FIBROMYALGIA: A RANDOMIZED CONTROLLED TRIAL
26. Recommendations for the treatment of Sjögren's syndrome
27. Validation and psychometric properties of the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI) into Brazilian Portuguese
28. Assessment of fatigue and dryness in primary Sjögren's syndrome: Brazilian version of “Profile of Fatigue and Discomfort – Sicca Symptoms Inventory (short form) (PROFAD-SSI-SF)”
29. Evaluation of performance of BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) in a Brazilian cohort of 1492 patients with spondyloarthritis: data from the Brazilian Registry of Spondyloarthritides (RBE)
30. Isolated atrophy of the abductor digiti quinti in patients with rheumatoid arthritis
31. Pesquisas em vacinas contra a Covid-19 de interesse para o sistema público de saúde: uma experiência de integração de instituições de ensino e pesquisa com o Sistema Único de Saúde do Brasil
32. Unbalanced networks and disturbed kinetics of serum soluble mediators associated with distinct disease outcomes in severe COVID-19 patients
33. Epidemiologic profile of juvenile-onset compared to adult-onset spondyloarthritis in a large Brazilian cohort
34. Profile of the use of disease modifying drugs in the Brazilian Registry of Spondyloarthritides
35. IV Brazilian Guidelines for autoantibodies on HEp-2 cells
36. Comparison Of The Immunogenicity Among Covid-19 Vaccines Chadox1, Coronavac Or Bnt162b2 In Systemic Lupus Erythematosus (Sle): A Prospective Cohort
37. ARTICULAR SYSTEMIC DISEASE ACTIVITY AT DIAGNOSIS IS ASSOCIATED WITH DAMAGE, FATIGUE, PAIN AND DRYNESS OVER TIME IN PRIMARY SJÖGREN’S SYNDROME
38. SAFETY OF THE CORONAVAC AND CHADOX 1 COVID-19 VACCINES IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM SAFER STUDY
39. FATIGUE IS ASSOCIATED WITH SYMPTOMS, DEPRESSION, ANXIETY, SLEEPINESS AND DISEASE ACTIVITY IN PRIMARY SJÖGREN’S SYNDROME
40. Safety assessment of BNT162b2, SinoVac and ChAdOx1 vaccines in Systemic Lupus Erythematosus patients – Data from SAFER Study
41. DIFFICULT ACCESS TO PREVENTION AND DETECTION MEASURES OF COVID-19 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
42. VALIDITY AND RELIABILITY OF THE BRAZILIAN VERSION OF THE PRIMARY SJÖGREN’S SYNDROME QUESTIONNAIRE
43. IMMUNOGENICITY AND SAFETY OF THE CHADOX-1 COVID-19 VACCINE IN PATIENTS WITH AUTOIMMUNE DISEASES AND HEALTHY CONTROLS: DATA FROM SAFER STUDY
44. Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis
45. Enteropathic arthritis in Brazil: data from the Brazilian registry of spondyloarthritis
46. Transcultural adaptation of the “EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI)” into Brazilian Portuguese
47. Primary Sjögren's syndrome prevalence in a major metropolitan area in Brazil
48. Current Approach to Dry Eye Disease
49. Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL
50. REATOGENICIDADE COM MEIA DOSE DA VACINA CHADOX1 NCOV-19 (AZD1222)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.